A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis.

A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis.

Item
http://www.wikidata.org/entity/Q33897070
Aurora Kinase Inhibitors: Current Status and OutlookRecent advances in the development of Aurora kinases inhibitors in hematological malignanciesAurora kinases: novel therapy targets in cancersTherapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicMicrotubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma.Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013).Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia.Multi-kinase inhibitors, AURKs and cancer.A population pharmacokinetic model of AT9283 in adults and children to predict the maximum tolerated dose in children with leukaemia.A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.The unpredictable Northern light: The rise and fall of the aurora kinase inhibitors?
P2860

A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis.

Item
http://www.wikidata.org/entity/Q33897070
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A phase I and pharmacodynamic ...... ory leukemia or myelofibrosis.
@ast
A phase I and pharmacodynamic ...... ory leukemia or myelofibrosis.
@en
type
label
A phase I and pharmacodynamic ...... ory leukemia or myelofibrosis.
@ast
A phase I and pharmacodynamic ...... ory leukemia or myelofibrosis.
@en
prefLabel
A phase I and pharmacodynamic ...... ory leukemia or myelofibrosis.
@ast
A phase I and pharmacodynamic ...... ory leukemia or myelofibrosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
A phase I and pharmacodynamic ...... ory leukemia or myelofibrosis.
@en
P2093
P2860
P304
P31
P356
10.1016/J.CLML.2013.11.001
P407
P433
P478
P50
P577
P698
P921
P932